AU1334799A - Novel cytokine receptors - Google Patents

Novel cytokine receptors

Info

Publication number: AU1334799A
Authority: AU; Australia
Prior art keywords: cytokine receptors; novel cytokine; novel; receptors; cytokine
Prior art date: 1997-10-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU13347/99A

Inventor

Greg Elson

Jean-Francois Gauchat

Marie Kosco-Vilbois

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-16

Filing date

1998-10-14

Publication date

1999-05-10

1998-10-14 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1999-05-10 Publication of AU1334799A publication Critical patent/AU1334799A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Zoology (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU13347/99A 1997-10-16 1998-10-14 Novel cytokine receptors Abandoned AU1334799A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9721961		1997-10-16
GBGB9721961.2A GB9721961D0 (en)	1997-10-16	1997-10-16	Novel molecules
PCT/EP1998/006497 WO1999020755A2 (en)	1997-10-16	1998-10-14	Novel cytokine receptors

Publications (1)

Publication Number	Publication Date
AU1334799A true AU1334799A (en)	1999-05-10

Family

ID=10820679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU13347/99A Abandoned AU1334799A (en)	1997-10-16	1998-10-14	Novel cytokine receptors

Country Status (5)

Country	Link
EP (1)	EP1027438A2 (en)
JP (1)	JP2002508922A (en)
AU (1)	AU1334799A (en)
GB (1)	GB9721961D0 (en)
WO (1)	WO1999020755A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999035264A1 (en) *	1998-01-09	1999-07-15	Immunex Corporation	H14 dna and polypeptides
US6060276A (en) *	1998-01-22	2000-05-09	Regeneron Pharmaceuticals, Inc.	Nucleic acids encoding novel orphan cytokine receptors
WO1999053066A1 (en) *	1998-04-10	1999-10-21	Genetics Institute, Inc.	U4, a member of the hematopoietin receptor superfamily
US6800460B1 (en)	1999-03-11	2004-10-05	Schering Corporation	Mammalian cytokine complexes
JP2003500010A (en) *	1999-03-11	2003-01-07	シェリング・コーポレーション	Mammalian cytokines; related reagents and methods
MXPA01012331A (en) *	1999-06-01	2002-07-30	Schering Corp	Mammalian receptor proteins; related reagents and methods.
JP6692826B2 (en)	2015-03-10	2020-05-13	アドゥロバイオテック，インク．	Compositions and methods for activation of "interferon gene stimulator" dependent signaling
GB201522186D0 (en)	2015-12-16	2016-01-27	Singapore Health Services Pte Ltd And Nat University Of Singapore The	Treatment of fibrosis
GB201621431D0 (en)	2016-12-16	2017-02-01	Singapore Health Services Pte Ltd And Nat Univ Of Singapore The	Decoy cytokine receptor
US20180186871A1 (en)	2016-12-16	2018-07-05	Singapore Health Services Pte Ltd.	Il-11 antibodies
GB201621439D0 (en)	2016-12-16	2017-02-01	Singapore Health Services Pte Ltd And Nat Univ Of Singapore	IL-11Ra Antibodies
KR20210138579A (en)	2019-01-21	2021-11-19	싱가포르 헬스 서비시즈 피티이 엘티디	Treatment of hepatotoxicity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPN564195A0 (en) *	1995-09-26	1995-10-19	Walter And Eliza Hall Institute Of Medical Research, The	A novel haemopoietin receptor and genetic sequences encoding same
ES2334408T3 (en) *	1995-10-23	2010-03-09	Zenyth Operations Pty Ltd	HEMATOPOYETINE RECEIVER AND GENETIC SEQUENCES THAT CODE IT.
AUPO224696A0 (en) *	1996-09-11	1996-10-03	Amrad Operations Pty. Limited	A novel haemopoietin receptor and genetic sequences encoding same
AU5733898A (en) *	1997-01-16	1998-08-07	Genetics Institute Inc.	Member of the hematopoietin receptor superfamily
AU7276098A (en) *	1997-05-01	1998-11-24	Zymogenetics Inc.	Mammalian cytokine-like receptor

1997
- 1997-10-16 GB GBGB9721961.2A patent/GB9721961D0/en not_active Ceased
1998
- 1998-10-14 JP JP2000517076A patent/JP2002508922A/en active Pending
- 1998-10-14 EP EP98956844A patent/EP1027438A2/en not_active Withdrawn
- 1998-10-14 WO PCT/EP1998/006497 patent/WO1999020755A2/en not_active Ceased
- 1998-10-14 AU AU13347/99A patent/AU1334799A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999020755A3 (en)	1999-07-29
JP2002508922A (en)	2002-03-26
EP1027438A2 (en)	2000-08-16
WO1999020755A2 (en)	1999-04-29
GB9721961D0 (en)	1997-12-17

Publication	Publication Date	Title
AU6535098A (en)	1998-09-09	Zcytor7 cytokine receptor
AU6873398A (en)	1999-04-12	Table construction
AU1027499A (en)	1999-04-23	32P-polyphosphazene
AU7966098A (en)	1998-12-30	Hm74a receptor
AU7132898A (en)	1998-11-13	Edg-1-like receptor
AU9066598A (en)	1999-03-01	Substituted 4-benzoyl-pyrazoles
AU8391498A (en)	1999-02-08	Semaphorin receptors
AU1334799A (en)	1999-05-10	Novel cytokine receptors
AU5104799A (en)	2000-02-28	Novel orphan cytokine receptors
AU8165298A (en)	1999-01-19	Cardiotrophin-like cytokine
AU1535699A (en)	1999-06-15	Novel receptors opg-2
EP0903415A3 (en)	2003-01-29	Structure expansée
AU8749998A (en)	1999-03-16	Neovascularization promoters
AU7165998A (en)	1998-12-30	Neurotrophic factor receptors
AUPO938697A0 (en)	1997-10-16	Novel receptor
AU6673898A (en)	1998-09-22	Factor x variant
AU8072498A (en)	1999-01-04	Heregulin-like factor
AU7583898A (en)	1998-12-11	Gdnf receptors
AU4411699A (en)	1999-12-20	Interferon receptor hkaef92
AU6090898A (en)	1998-07-31	Substituted 4-benzoyl-pyrazoles
AU8736698A (en)	1999-03-08	Shale-stabilizing additives
AU7539498A (en)	1998-12-11	Elevated paving structure
AU3543599A (en)	1999-10-18	Receptors
EP0904287A3 (en)	2000-12-20	Cytokine designated lerk-8
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists

Legal Events

Date	Code	Title	Description
2000-06-29	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase